SGLT2 inhibitors and finerenone in non-diabetic CKD: a step into the (near) future?
Marieta Theodorakopoulou, Pantelis Sarafidis
Topics & Concepts
MedicineInternal medicineDiabetes Treatment and ManagementHormonal Regulation and HypertensionPharmacology and Obesity Treatment